Alejandro Dorenbaum is Chief Medical Officer of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 30,000 shares of RPHM, which is worth approximately $50,400. The most recent transaction as insider was on Aug 12, 2022, when has been sold 22,348 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30K
0% 3M change
0% 12M change
Total Value Held $50,400

Alejandro Dorenbaum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2022
SELL
Bona fide gift
-
22,348 Reduced 42.69%
30,000 Common Stock
Dec 10 2021
BUY
Grant, award, or other acquisition
-
30,000 Added 36.43%
52,348 Common Stock
AD

Alejandro Dorenbaum

Chief Medical Officer
Irvine, CA

Track Institutional and Insider Activities on RPHM

Follow Reneo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

News

Receive news related to Reneo Pharmaceuticals, Inc.

Track Activities on RPHM